Clinical trial
Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
NCT05273138 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
- Lead sponsor
- University Hospital, Lille
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 8, 2022
- Completion date
- June 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic sclerosis